New tech aims to reduce racial disparities in blood measurements

New tech aims to reduce racial disparities in blood measurements
UTA and Shani Technologies are working on the device. Credit: University of Texas at Arlington

A team led by a University of Texas at Arlington bioengineering professor and an Austin businessman has published key findings in the BMJ Innovations that illustrate how a new device measures hemoglobin more accurately in individuals with darker skin pigmentations.

George Alexandrakis, UT Arlington bioengineering professor, and Dr. Vinoop Daggubati of Shani Biotechnologies LLC conducted a at UT Arlington with 16 healthy volunteers and measured their hemoglobin and using the newly developed technology. The team compared the results to those obtained using a commercially available pulse-oximeter for accuracy and variability.

Racial disparities in hemoglobin and blood oxygen measurements are an urgent public health issue. Currently available devices are inaccurate in people with dark skin. The U.S. Food and Drug Administration has issued a safety communication and organized an advisory committee meeting on Nov. 1, 2022, to discuss this issue at length.

The findings from the UTA team's research are encouraging, and the new technology has massive potential to address this clinical unmet need. Alexandrakis said their intent is to develop a wearable device, such as a watch or a monitor, that would read the blood through the skin.

Most currently available methods for monitoring hemoglobin require blood samples and expensive equipment. The available noninvasive spectroscopic methods have a high degree of variability and often are inaccurate in people of color due to differences in skin melanin. There is a significant unmet need for a reliable, noninvasive device to estimate hemoglobin, irrespective of skin color.

Currently available pulse-oximeters use red-infrared light and are based on technology first designed more than 50 years ago. In , the team's device relies on the spectroscopic properties of hemoglobin in the blue-green light spectra.

"We have used the green-blue light and have successfully tested the device in preclinical and ," Daggubati said. "Our group has addressed the issues around shorter wavelength, scattering of light and the impact of skin melanin. The should open its mind to the concept of green light for these measurements. The Shani device has huge potential to eliminate this racial disparity."

More information: Sanjay G Gokhale et al, Innovative technology to eliminate the racial bias in non-invasive, point-of-care (POC) haemoglobin and pulse oximetry measurements, BMJ Innovations (2022). DOI: 10.1136/bmjinnov-2022-001018

Citation: New tech aims to reduce racial disparities in blood measurements (2022, October 28) retrieved 8 February 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Wearable device could reduce racial disparities in blood measurements


Feedback to editors